Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

370 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area.
Araki T, Wake R, Miyaoka T, Kawakami K, Nagahama M, Furuya M, Limoa E, Liaury K, Hashioka S, Murotani K, Horiguchi J. Araki T, et al. Among authors: murotani k. Int J Geriatr Psychiatry. 2014 Sep;29(9):881-9. doi: 10.1002/gps.4074. Epub 2014 Jan 17. Int J Geriatr Psychiatry. 2014. PMID: 24436135 Clinical Trial.
Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis).
Miyaoka T, Furuya M, Horiguchi J, Wake R, Hashioka S, Tohyama M, Mori N, Minabe Y, Iyo M, Ueno S, Ezoe S, Murotani K, Hoshino S, Seno H. Miyaoka T, et al. Among authors: murotani k. Psychopharmacology (Berl). 2015 Jan;232(1):155-64. doi: 10.1007/s00213-014-3645-8. Epub 2014 Jun 13. Psychopharmacology (Berl). 2015. PMID: 24923986 Clinical Trial.
Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, multicenter, double-blind, placebo-controlled trial.
Miyaoka T, Furuya M, Horiguchi J, Wake R, Hashioka S, Thoyama M, Murotani K, Mori N, Minabe Y, Iyo M, Ueno S, Ezoe S, Hoshino S, Seno H. Miyaoka T, et al. Among authors: murotani k. Evid Based Complement Alternat Med. 2015;2015:201592. doi: 10.1155/2015/201592. Epub 2015 Apr 14. Evid Based Complement Alternat Med. 2015. PMID: 25954314 Free PMC article.
Effectiveness of educational program using printed educational material on care burden distress among staff of residential aged care facilities without medical specialists and/or registered nurses: Cluster quasi-randomization study.
Fukuda K, Terada S, Hashimoto M, Ukai K, Kumagai R, Suzuki M, Nagaya M, Yoshida M, Hattori H, Murotani K, Toba K. Fukuda K, et al. Among authors: murotani k. Geriatr Gerontol Int. 2018 Mar;18(3):487-494. doi: 10.1111/ggi.13207. Epub 2017 Nov 15. Geriatr Gerontol Int. 2018. PMID: 29143427 Clinical Trial.
A Randomized Trial of a Short 34-Gauge Needle for Intravitreal Injections.
Sasajima H, Tsuboi K, Ono H, Murotani K, Kamei M. Sasajima H, et al. Among authors: murotani k. Ophthalmology. 2018 Jun;125(6):947-948. doi: 10.1016/j.ophtha.2018.01.038. Epub 2018 Mar 2. Ophthalmology. 2018. PMID: 29501210 Clinical Trial. No abstract available.
370 results